Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
10,284
Total Claims
$1.0M
Drug Cost
589
Beneficiaries
$1,704
Cost/Patient
Risk Score Breakdown 9/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-90%
Opioid rate vs peers
0.2% vs 2.2% avg
+21%
Cost per patient vs peers
$1,704 vs $1,411 avg
+9%
Brand preference vs peers
11.6% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
0.2%
Opioid Rate
23
Opioid Claims
$178
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,179 claims · $797K
Generic: 8,992 claims · $201K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 166 | $121K |
| Empagliflozin | 85 | $98K |
| Fluticasone/Umeclidin/Vilanter | 93 | $79K |
| Semaglutide | 49 | $58K |
| Sitagliptin Phosphate | 48 | $55K |
| Insulin Glargine,hum.Rec.Anlog | 31 | $34K |
| Semaglutide | 26 | $34K |
| Sacubitril/Valsartan | 28 | $28K |
| Linaclotide | 44 | $26K |
| Empagliflozin/Linagliptin | 27 | $24K |
| Rivaroxaban | 23 | $22K |
| Dulaglutide | 14 | $21K |
| Atorvastatin Calcium | 1,023 | $20K |
| Insulin Aspart | 11 | $15K |
| Dapagliflozin Propanediol | 15 | $14K |
Prescribing Profile
Patient Profile
74
Avg Age
55%
Female
1.33
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About